Summit Therapeutics Inc. balance sheet

At the end of fiscal 2024, Summit Therapeutics Inc. had total assets of $436m, total liabilities of $46.8m and shareholders' equity of $389m. It held $105m in cash against $0 of debt: net cash of $105m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Summit Therapeutics Inc.: balance sheet, annual
Fiscal year	2016Jan 2016	2017Jan 2017	2018Jan 2018	2019Jan 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024
Cash and equivalents	—	—	—	—	66	72	349	71	105
Receivables	—	—	—	—	0	1	0	0	—
Total current assets	—	—	—	—	88	97	657	190	424
Goodwill	—	—	—	2	2	2	2	2	2
Total assets	—	—	—	—	102	113	664	203	436
Accounts payable	—	—	—	—	6	4	0	3	5
Deferred revenue (current)	—	—	—	—	8	8	0	—	—
Total current liabilities	—	—	—	—	20	26	39	20	42
Long-term debt	—	—	—	—	—	—	495	100	0
Total debt	—	—	—	0	0	0	514	100	0
Total liabilities	—	—	—	—	23	30	538	125	47
Shareholders' equity	—	—	−4	58	79	83	127	78	389
Net debt (negative = net cash)	—	—	—	—	−66	−72	166	29	−105
Shares outstanding	—	—	—	—	—	196m	211m	702m	738m

US$ millions unless shown otherwise. Fiscal quarters.

Summit Therapeutics Inc.: balance sheet, quarterly
Quarter	2022 Q3Sept 2022	2022 Q4Dec 2022	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023	2024 Q3Sept 2024	2024 Q4Dec 2024
Receivables	0	0	0	0	0	0	—	—
Total current assets	137	657	248	228	205	190	490	424
Goodwill	2	2	2	2	2	2	2	2
Total assets	155	664	255	237	218	203	503	436
Accounts payable	1	0	1	1	3	3	3	5
Deferred revenue (current)	0	0	0	0	0	—	—	—
Total current liabilities	17	39	17	12	114	20	59	42
Long-term debt	—	495	—	100	0	100	0	0
Total debt	—	495	—	100	0	100	0	0
Total liabilities	22	538	121	118	119	125	65	47
Shareholders' equity	133	127	133	120	99	78	438	389
Shares outstanding	201m	211m	698m	698m	698m	702m	737m	738m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Summit Therapeutics Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Summit Therapeutics Inc.